ace2

Open Access
A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids
Jan Wysocki, Minghao Ye, Luise Hassler, Ashwani Kumar Gupta, Yuguo Wang, Vlad Nicoleascu, Glenn Randall, Jason A. Wertheim and Daniel Batlle

JASN April 2021, 32 (4) 795-803; DOI: https://doi.org/10.1681/ASN.2020101537

Add to Selected Citations
Open Access
Does SARS-CoV-2 Infect the Kidney?
Shaza Khan, Lihe Chen, Chin-Rang Yang, Viswanathan Raghuram, Syed J. Khundmiri and Mark A. Knepper

JASN December 2020, 31 (12) 2746-2748; DOI: https://doi.org/10.1681/ASN.2020081229

Add to Selected Citations
Open Access
Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
Jan Wysocki, Enrique Lores, Minghao Ye, Maria Jose Soler and Daniel Batlle

JASN September 2020, 31 (9) 1941-1943; DOI: https://doi.org/10.1681/ASN.2020050667

Add to Selected Citations
Open Access
Authors’ Reply
Daniel Batlle, Maria Jose Soler, Paul A. Welling, Sundararaman Swaminathan and on behalf of the COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group*

JASN August 2020, 31 (8) 1918-1919; DOI: https://doi.org/10.1681/ASN.2020060799

Add to Selected Citations
Open Access
Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology
Daniel Batlle, Maria Jose Soler, Matthew A. Sparks, Swapnil Hiremath, Andrew M. South, Paul A. Welling, Sundararaman Swaminathan and on behalf of the COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group

JASN July 2020, 31 (7) 1380-1383; DOI: https://doi.org/10.1681/ASN.2020040419

Add to Selected Citations

Main menu

User menu

Search

ace2

Articles

Information for Authors

About

Journal Information

More Information